Showing results (1351-1360 of 1,436) with videos related to
Sort By:
Pageof 144
European Urology Focus|April 5, 2023
Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral NeuromodulationEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.Organic Process Research & Development|August 8, 2023
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19Christophe Allais, David Bernhardson, Adam R Brown, et al.Journal of Personalized Medicine|December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic CholangiocarcinomaBrian De, Ibrahim Abu-Gheida, Aashini Patel, et al.European Urology Focus|September 10, 2020
Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational StudyEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.The Journal of Clinical Investigation|October 5, 2016
Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpointTineke Cantaert, Jean-Nicolas Schickel, Jason M Bannock, et al.Annals of Surgery|July 18, 2020
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center ExperienceChing-Wei D Tzeng, Mediget Teshome, Matthew H G Katz, et al.Oncology|October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma PatientsReham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORSYago Nieto, John F Ward, Wayne Hofstetter, et al.Molecular and Cellular Endocrinology|February 10, 2018
Regulatory identification of BPA as an endocrine disruptor: Context and methodologyClaire Beausoleil, Claude Emond, Jean-Pierre Cravedi, et al.Nature Nanotechnology|April 22, 2022
Single-crystalline TiO<sub>2</sub> nanoparticles for stable and efficient perovskite modulesYong Ding, Bin Ding, Hiroyuki Kanda, et al.Pageof 144